BCN BIOSCIENCES, LLC

Basic Information

2275 E FOOTHILL BLVD
PASADENA, CA, 91107-3658

Company Profile

n/a

Additional Details

Field Value
DUNS: 788136880
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. A dual acting drug for enhancing radiotherapeutic benefit

    Amount: $209,208.00

    ABSTRACT: This proposal entitled A dual acting drug for enhancing radiotherapeutic benefit is designed to provide proof of concept evidence that the novel compound EWA001 can protect normal lung ti ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. A novel targeted therapy

    Amount: $160,735.00

    DESCRIPTION (provided by applicant): Cancer is the leading cause of mortality in the United States, despite many advances in the current therapies including surgery, radiation and chemotherapy. Theref ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Translational research in a novel anti cancer agent

    Amount: $99,510.00

    DESCRIPTION (provided by applicant): Natural products possess the richest source of molecular diversity in existence. In the case of cancer therapeutics, natural products have yielded a significant nu ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. Botanical-derived drug discovery for cancer therapy

    Amount: $130,207.00

    DESCRIPTION (provided by applicant): In a screen for naturally occurring angiogenic inhibitors, we have identified an extract from the plant Livistona chinensis, which has potent anti-angiogenic and a ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government